Propranolol Treatment for Postoperative Chylothorax

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 9, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

January 1, 2031

Conditions
Postoperative ChylothoraxCongenital Heart DiseaseOpen Heart SurgeryChylothorax
Interventions
DRUG

Propranolol Hydrochloride

Propranolol will be administered as tablets. Participants who are too young to swallow pills will be given propranolol solution.

DRUG

Placebo

Placebo suspension will only have Ora-Blend Medication Flavoring and Suspension Vehicle

Trial Locations (1)

10032

RECRUITING

Columbia University Irving Medical Center/NewYork-Presbyterian, New York

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

June Wu

OTHER

NCT06833320 - Propranolol Treatment for Postoperative Chylothorax | Biotech Hunter | Biotech Hunter